QLT Inc. (QLTI) to Cut Workforce by 42%
QLT Inc. (Nasdaq: QLTI) announced a 42% reduction of its workforce to better align its resources with the Company's corporate objectives following the recent sale of Visudyne® to Valeant Pharmaceuticals International, Inc. ("Valeant"). QLT expects to record a restructuring charge of approximately $2.0 million relating to this reduction in force. The Company also expects the reorganization to result in approximately $3.8 million in reduced annualized expenses once the reduction is fully implemented in the first half of 2013.
You May Also Be Interested In
- Auxilium Pharma (AUXL) Says Endo (ENDP) is Not Superior (QLTI)
- Rockwell Collins (COL) Guides FY15 Inline; Adds $500M to Buyback Plan
- QLT, Inc. (QLTI) Comments on Auxilium Pharmaceuticals (AUXL) Takeover Approach by Endo
Create E-mail Alert Related CategoriesCorporate News, Guidance, Hot Corp. News
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!